Listen to experienced IP professionals discuss how best to right size your IP spending to strike the right balance between reducing IP costs and building your company’s IP position and technology value. This panel discusses how the changing IP regulatory environment may impact these decisions.
Moderator: John T. Gutkoski
David Cerveny, Vice President Intellectual Property and General Counsel, ConforMIS, Inc.
Wendy Rieder, General Counsel and Vice President Intellectual Property and Legal Affairs, Synta Pharmaceuticals Corp.
Steve Tannenbaum, Executive Vice President and Chief Financial Officer, Collegium Pharmaceutical, Inc.